ResearcherVanderbilt UniversityNo recent work listed

Marc T Roth

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7231-4119; OpenAlex author ID A5042750300. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2020: 2 papers

Papers 2

Recent advances in the treatment of pancreatic cancer. Co-author DOI 10.12688/f1000research.21981.1 ↗
A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma. Co-author DOI 10.1634/theoncologist.2020-0440 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dana Backlund Cardin · 2 shared papers, 2020 · strength 0.30
- Paper Recent advances in the treatment of pancreatic cancer. DOI 10.12688/f1000research.21981.1 ↗
- Paper A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV … DOI 10.1634/theoncologist.2020-0440 ↗
Jordan D. Berlin · 2 shared papers, 2020 · strength 0.30
- Paper Recent advances in the treatment of pancreatic cancer. DOI 10.12688/f1000research.21981.1 ↗
- Paper A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV … DOI 10.1634/theoncologist.2020-0440 ↗
Robert Alan Newman · 1 shared paper, 2020 · strength 0.11
- Paper A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV … DOI 10.1634/theoncologist.2020-0440 ↗
Raymond Couric Wadlow · 1 shared paper, 2020 · strength 0.11
- Paper A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV … DOI 10.1634/theoncologist.2020-0440 ↗
Erkut Hasan Borazanci · 1 shared paper, 2020 · strength 0.11
- Paper A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV … DOI 10.1634/theoncologist.2020-0440 ↗
Vincent J. Picozzi · 1 shared paper, 2020 · strength 0.11
- Paper A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV … DOI 10.1634/theoncologist.2020-0440 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.